carvedilol has been researched along with Active Hyperemia in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Peak reactive hyperemia (mL." | 6.68 | Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure. ( Bijou, R; Demopoulos, L; Gentilucci, M; Jones, M; Katz, SD; LeJemtel, TH; Mancini, D; Testa, M; Yeh, M, 1997) |
"Peak reactive hyperemia (mL." | 2.68 | Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure. ( Bijou, R; Demopoulos, L; Gentilucci, M; Jones, M; Katz, SD; LeJemtel, TH; Mancini, D; Testa, M; Yeh, M, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demopoulos, L | 1 |
Yeh, M | 1 |
Gentilucci, M | 1 |
Testa, M | 1 |
Bijou, R | 1 |
Katz, SD | 1 |
Mancini, D | 1 |
Jones, M | 1 |
LeJemtel, TH | 1 |
1 trial available for carvedilol and Active Hyperemia
Article | Year |
---|---|
Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Aerobiosis; Aged; Angiotensin-Converting Enz | 1997 |